Despite tremendous research efforts, treatment options for many neurological disorders are inadequate. Systemic drug treatments suffer from side effects and long-term habituation; electrical stimulation is unspecific; and the fluidic injection of drugs often displaces the very cells that are being targeted due to the local pressure increase. Thus, there exists a pressing need to develop novel treatment strategies that overcome these limitations. One such technology is the recently introduced drug delivery platform known as the microfluidic ion pump (µFIP). The µFIP is an implantable device that electrophoretically pumps ions (eg. neurotransmitters, drugs, etc) to the target tissue. In addition to spatial and temporal control, a distinctive feature of the µFIP is that it delivers just the ion and not the solvent and thus does not increase pressure at the outlet. This “dry” delivery is of paramount importance for neural interfacing as it enables an intimate interface between the drug delivery outlet and the target cells. Here we report recent advances in µFIPs and related drug delivery device concepts for treating neurological disorders with a focus on material developments and limitations as well as progress toward clinical applications.
Here we report recent advances in precise engineering to incorporate advanced electrophoretic drug delivery system into implantable devices for treating neurological disorders including both depth probes and cortical arrays with recording capabilities. The efficacy of the platform is demonstrated by stopping epileptic seizures in vivo. This is the first in vivo demonstration of an electrophoretic implant treating a neurological disorder and offers a glimpse of what can be achieved by tailored engineering of electrophoretic devices. We anticipate this work to be the starting point for new stimulation, recording and drug delivery paradigms in chronic neural implantation.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.